Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash from Financing
$4,171 Mil (TTM As of Jun. 2016)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2016, Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back shares than it received from issuing new shares. It received $719 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $376 Mil paying cash dividends to shareholders. It spent $64 Mil on other financial activities. In all, Teva Pharmaceutical Industries Ltd earned $279 Mil on financial activities for the three months ended in Jun. 2016.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Teva Pharmaceutical Industries Ltd's Cash from Financing for the fiscal year that ended in Dec. 2015 is calculated as:

Cash from Financing(A: Dec. 2015 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=2852+-393+3291+-1155+210
=4,805

Teva Pharmaceutical Industries Ltd's Cash from Financing for the quarter that ended in Jun. 2016 is

Teva Pharmaceutical Industries Ltd Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2016 was -1090 (Sep. 2015 ) + 4715 (Dec. 2015 ) + 267 (Mar. 2016 ) + 279 (Jun. 2016 ) = $4,171 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Teva Pharmaceutical Industries Ltd's net issuance of stock for the three months ended in Jun. 2016 was $0 Mil. Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Teva Pharmaceutical Industries Ltd's net issuance of debt for the three months ended in Jun. 2016 was $719 Mil. Teva Pharmaceutical Industries Ltd received $719 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Teva Pharmaceutical Industries Ltd's net issuance of preferred for the three months ended in Jun. 2016 was $0 Mil. Teva Pharmaceutical Industries Ltd paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Teva Pharmaceutical Industries Ltd's cash flow for dividends for the three months ended in Jun. 2016 was $-376 Mil. Teva Pharmaceutical Industries Ltd spent $376 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Teva Pharmaceutical Industries Ltd's other financing for the three months ended in Jun. 2016 was $-64 Mil. Teva Pharmaceutical Industries Ltd spent $64 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Net Issuance of Stock -546000-99-899-1,161-497-5002,852
Net Issuance of Debt 2,264-1581,678-1,882-1,3465,034319-2,411-1,224-393
Net Issuance of Preferred 0000000003,291
Dividends -229-299-388-529-668-800-855-1,089-1,156-1,155
Other Financing 4335681462,686119114505210
Cash from Financing 2,024-3621,358-2,2655733,336-1,678-3,883-2,3754,805

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Net Issuance of Stock 0000-4390003290
Net Issuance of Debt -433-628-108-557041,389-874-1,612-6719
Net Issuance of Preferred 000000003290
Dividends -291-299-294-272-290-288-287-290-367-376
Other Financing 9010873-266118-14716,617-18-64
Cash from Financing -634-819-329-593931,087-1,0904,715267279
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK